Descriptor English: | Labetalol | ||||||
Descriptor Spanish: |
Labetalol
| ||||||
Descriptor Portuguese: | Labetalol | ||||||
Descriptor French: | Labétalol | ||||||
Entry term(s): |
AH 5158 AH-5158 AH5158 Albetol Apo Labetalol Apo-Labetalol ApoLabetalol Dilevalol Hydrochloride, Labetalol Labetalol Hydrochloride Labetalol, (R,R)-Isomer Labetolol Normodyne Presolol R,R Labetalol R,R-Labetalol SCH 19927 SCH-19927 SCH19927 Trandate |
||||||
Tree number(s): |
D02.033.100.291.460 D02.065.793.324 D02.092.063.291.460 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D007741 | ||||||
Scope note: | A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Adrenergic beta-Antagonists Antihypertensive Agents Sympathomimetics Adrenergic alpha-1 Receptor Antagonists |
||||||
Registry Number: | R5H8897N95 | ||||||
CAS Type 1 Name: | Benzamide, 2-hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)- | ||||||
Previous Indexing: |
Butylamines (1974) Ethanolamines (1974) Salicylamides (1974) |
||||||
Public MeSH Note: | 86; was see under ETHANOLAMINES 1978-85; was AH 5158 see under ETHANOLAMINES 1975-77 |
||||||
Online Note: | use LABETALOL to search AH 5158 1975-77 |
||||||
History Note: | 86(78); was see under ETHANOLAMINES 1978-85; was AH 5158 see under ETHANOLAMINES 1975-77 |
||||||
DeCS ID: | 7918 | ||||||
Unique ID: | D007741 | ||||||
NLM Classification: | QV 151 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1986/01/01 | ||||||
Date of Entry: | 1974/11/19 | ||||||
Revision Date: | 2016/07/01 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals
|
Labetalol
- Preferred
Albetol
- Narrower
Apo-Labetalol
- Narrower
Trandate
- Narrower
Labetalol Hydrochloride
- Narrower
Normodyne
- Narrower
Presolol
- Narrower
SCH-19927
- Narrower
AH-5158
- Narrower
Dilevalol
- Narrower
Concept UI |
M0012098 |
Scope note | A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS. |
Preferred term | Labetalol |
Entry term(s) |
Labetolol |
Concept UI |
M0012101 |
Preferred term | Albetol |
Concept UI |
M0463249 |
Preferred term | Apo-Labetalol |
Entry term(s) |
Apo Labetalol ApoLabetalol |
Concept UI |
M0012099 |
Preferred term | Trandate |
Concept UI |
M0463248 |
Preferred term | Labetalol Hydrochloride |
Entry term(s) |
Hydrochloride, Labetalol |
Concept UI |
M0012100 |
Preferred term | Normodyne |
Concept UI |
M0463250 |
Preferred term | Presolol |
Concept UI |
M0012097 |
Preferred term | SCH-19927 |
Entry term(s) |
SCH 19927 SCH19927 |
Concept UI |
M0012102 |
Preferred term | AH-5158 |
Entry term(s) |
AH 5158 AH5158 |
Concept UI |
M0354778 |
Preferred term | Dilevalol |
Entry term(s) |
Labetalol, (R,R)-Isomer R,R Labetalol R,R-Labetalol |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey